Where it makes an impact

Real-world applications.

From the clinic to the laboratory bench — the same engine, applied to the questions each audience actually owns.

Personalised diagnosis and treatment selection guided by whole-biology signatures rather than population averages.

Find targets, predict efficacy and optimise candidates faster — failing in silico rather than in the clinic.

Predictive biomarkers enabling proactive, preventive care ahead of clinical onset.

Multi-omic tumour insight to understand mechanism and guide precision therapies.

Clinical solutions

Powering four Soma Nova solutions.

Shorten the diagnostic odyssey.

Match the tumour to the therapy.

Genomics at national scale.

Right drug, right dose — pre-emptively.

Beyond the clinic

Research groupsCohort-scale multi-omic analysis with federated execution — models move to data, so cohorts need not be centralised.

Drug discoveryTarget identification and validation, with mechanism explained rather than merely correlated.

BiobanksInterpretation at cohort scale with sovereignty and consistency guarantees.

Partners building on the engineAPI access behind the gateway, with FHIR-native output.

Get started

Clinical programme, research group, or partner building on the engine — tell us which.